The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 347:1889-1890 December 5, 2002 Number 23
NextNext

Drug Resistance among Patients Recently Infected with HIV

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Little, S. J.
-PubMed Citation
To the Editor: The retrospective analysis by Little et al. (Aug. 8 issue)1 provides further evidence of the transmission of drug-resistant human immunodeficiency virus type 1 (HIV-1)2 and attempts to relate detection of resistant virus before antiretroviral therapy to suboptimal virologic response. However, the authors' recommendations for universal base-line resistance testing and abandonment of empirical treatment are premature.

Ascertainment of base-line viral resistance is not recommended by the current guidelines except in cases of virologic failure or incomplete viral suppression after initial therapy.3 Little et al. did show that the time to viral suppression was shorter and the time to . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.